Adapted Massed Exposure Therapy Enhanced with MDMA for PTSD (aMETEMP): A randomized, double-masked protocol adapted for Veterans Affairs healthcare system

Paper. Morland LA, Chargin B, Rothbaum B et al.. Contemporary Clinical Trials Communications, 27 Oct 2026.

Tags: Human, MDMA, PTSD.

Weekly Science Digest, 6 Nov 2026 to 12 Nov 2026, finding 5: In brief

protocol for MDMA added to three-week massed prolonged exposure in VA outpatients, using a 35–125 mg dose range instead of inert placebo

Read the original

—
Node—
Statuslive
Throughput—